Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...

Novel technologies are needed to facilitate large-scale detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific antibodies in human blood samples. Such technologies are ...

The SD Biosensor Standard Q COVID-19 Ag Test and Acon Biotech Flowflex SARS-CoV-2 Antigen Rapid Test were previously listed under WHO's emergency use listing.

The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...

More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic ...

SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

Rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are effective tools for the diagnosis of acute infection, particularly when used serially. 1 The percentage of ...

A research team from three Johns Hopkins institutions has shown that SARS-CoV-2, the virus that causes COVID-19, can “reprogram” pathogen-fighting white blood cells known as neutrophils (left side) ...

A serious pediatric illness has been linked to a similar condition in adults. Coronavirus inhabiting the gut could be the ...